Edition Junior Study - Helping patients with type 1 diabetes (T1D) to find better treatment options
32% lower incidence of hypoglycemia and 46% lower incidence of hyperglycemia with ketosis at month 6 were observed with Glargine 300 in the first head to head study comparing newer generation basal insulin analog vs Glargine 100 in pediatric diabetic pts.
![](/.imaging/webp/sanofi-templates/w1080-16-9/dam/campus-sanofi-ae/Articles/image-(22).jpg/jcr:content/image%20(22).jpg)
Related articles
MAT-BH-2300624/v1/Nov 2023